JANUMET Drug Profile, 2023 PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download JANUMET Drug Profile, 2023 PDF full book. Access full book title JANUMET Drug Profile, 2023 by DrugPatentWatch. Download full books in PDF and EPUB format.

JANUMET Drug Profile, 2023

JANUMET Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899623
Category : Medical
Languages : en
Pages : 155

Book Description

JANUMET Drug Profile, 2023

This report focuses on JANUMET and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


JANUMET Drug Profile, 2023

JANUMET Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899623
Category : Medical
Languages : en
Pages : 155

Book Description

JANUMET Drug Profile, 2023

This report focuses on JANUMET and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


JANUMET XR Drug Profile, 2023

JANUMET XR Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899569
Category : Medical
Languages : en
Pages : 174

Book Description

JANUMET XR Drug Profile, 2023

This report focuses on JANUMET XR and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


JANUVIA Drug Profile, 2023

JANUVIA Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899429
Category : Medical
Languages : en
Pages : 413

Book Description

JANUVIA Drug Profile, 2023

This report focuses on JANUVIA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


KAZANO Drug Profile, 2023

KAZANO Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899844
Category : Medical
Languages : en
Pages : 100

Book Description

KAZANO Drug Profile, 2023

This report focuses on KAZANO and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers


EDURANT Drug Profile, 2023

EDURANT Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899860
Category : Medical
Languages : en
Pages : 100

Book Description

EDURANT Drug Profile, 2023

This report focuses on EDURANT and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


McGraw Hill's 2022/2023 Top 300 Pharmacy Drug Cards

McGraw Hill's 2022/2023 Top 300 Pharmacy Drug Cards PDF Author: Jill M. Kolesar
Publisher: McGraw Hill Professional
ISBN: 126046735X
Category : Medical
Languages : en
Pages : 608

Book Description
The quickest, most efficient way for mastering critical facts about common drugs Perfect for NAPLEX and course review, McGraw-Hill's 2020/2021 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. Each card includes: Generic and common name Dosage Forms Approved Dose and Indications Off-Label Use Contraindications Adverse Reactions Drug Interactions Monitoring Parameters Medication Safety Issues and Black Box Warnings Strong focus on patient safety Adverse reactions are organized by common, less common, and rare but serious to help you organize your thoughts for counseling patients, and a downloadable audio link enable you to hear key information your device.

Type 2 Diabetes

Type 2 Diabetes PDF Author: Anthony Barnett
Publisher: Oxford University Press
ISBN: 0199596174
Category : Medical
Languages : en
Pages : 175

Book Description
This second edition has been updated throughout to aacount for the latest trial data, including new chapters on pathophysiology, and interpretation of recent clinical trials. This pocketbook is a concise, practical guide to the diagnosis, assessment and management of Type 2 Diabetes aimed at clinicians, GPs and nurse specialists.

Drug-Induced Liver Injury

Drug-Induced Liver Injury PDF Author:
Publisher: Academic Press
ISBN: 0128173173
Category : Medical
Languages : en
Pages : 290

Book Description
Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series

Take Control of Your Cancer Risk

Take Control of Your Cancer Risk PDF Author: John Whyte, MD, MPH
Publisher: Harper Horizon
ISBN: 0785240411
Category : Health & Fitness
Languages : en
Pages : 269

Book Description
Something everyone has the power to do is reduce your cancer risk, and this book will show you just how easy it is to do it. Each year, over a million people in the United States alone hear the words no one ever wants to hear: You have cancer. But what if there was a way for fewer people to hear these words? One of the biggest myths regarding cancer is that it’s mostly genetic - meaning that you have no control over whether you get it. While genetics do have an impact, the truth is that your lifestyle and environment play the major role. Physician and Chief Medical Offer of WebMD John Whyte, MD, MPH, shares straightforward information and equips you with strategies to help you on a journey to better health. In Take Control of Your Cancer Risk, Dr. Whyte provides helpful tips including: assessing your cancer risk knowing which screenings you need, and when learning the role food, exercise, and sleep play understanding the relationship between stress and cancer Take Control of Your Cancer Risk is filled with practical advice that empowers you to really take control of our health.

Emergency Care for Hazardous Materials Exposure

Emergency Care for Hazardous Materials Exposure PDF Author: Phillip L. Currance
Publisher: Mosby/JEMS
ISBN:
Category : Medical
Languages : en
Pages : 908

Book Description
This Revised Third Edition is now updated to reflect the 2005 emergency cardiac care guidelines. The need for hazardous materials emergency response has grown with the increased use of chemicals and the threat of terrorism. Designed for both the EMS field provider and first receivers in the hospital setting, this important resource provides field recognition and management guidelines for hazardous materials exposures and associated medical emergencies, including emergency care of exposed and contaminated patients. The 3rd edition has been expanded to provide responders with the information necessary to identify the scene of a terrorist act involving the use of hazardous materials, as well as triage procedures for chemical exposure and the management of a mass casualty incident. A total of 140 guidelines, cross-referenced to indexes, provide essential information on hazard classes and specific chemicals with initial hospital considerations. Descriptions of procedures, scene operations and support, medical surveillance, and suggested emergency equipment. Extensive indexes supply multiple ways to access important information to save critical time in the field. Content is updated to reflect the 2005 emergency cardiac care guidelines. Over 30 new WMD agent guidelines provide concise, consistent information on managing exposure to high-risk substances. Expanded size includes over 150 pages of new material. An expanded index and updated treatment guidelines are included. The treatment protocol section, drug protocol section, and EMS/hazardous materials operating procedures are updated and expanded. How to identify the scene of a terrorist act involving the use of hazardous materials. Information on mass casualty decontamination and crime scene identification will help reader formulate a plan before beginning to work.